Globus Medical, Inc.
GMED
$71.04
$1.361.95%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 5.05% | -0.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.05% | -0.63% | |||
| Cost of Revenue | 3.02% | 1.67% | |||
| Gross Profit | 6.07% | -1.75% | |||
| SG&A Expenses | 5.37% | 1.02% | |||
| Depreciation & Amortization | -0.55% | 1.24% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.42% | 0.66% | |||
| Operating Income | 12.64% | -6.24% | |||
| Income Before Tax | -56.75% | 19.86% | |||
| Income Tax Expenses | -135.37% | -67.16% | |||
| Earnings from Continuing Operations | -48.87% | 63.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -48.87% | 63.21% | |||
| EBIT | 12.64% | -6.24% | |||
| EBITDA | 8.60% | -2.20% | |||
| EPS Basic | -49.27% | 62.71% | |||
| Normalized Basic EPS | -26.62% | 2.82% | |||
| EPS Diluted | -50.00% | 65.22% | |||
| Normalized Diluted EPS | -26.88% | 2.33% | |||
| Average Basic Shares Outstanding | 0.82% | 0.31% | |||
| Average Diluted Shares Outstanding | 1.19% | 0.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
